跳转至内容
Merck

A76958

Sigma-Aldrich

氨基吡嗪

98%

别名:

2-氨基哌嗪

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C4H5N3
CAS号:
分子量:
95.10
Beilstein:
107025
EC號碼:
MDL號碼:
分類程式碼代碼:
12352100
PubChem物質ID:
NACRES:
NA.22

品質等級

化驗

98%

形狀

crystals

mp

118-120 °C (lit.)

SMILES 字串

Nc1cnccn1

InChI

1S/C4H5N3/c5-4-3-6-1-2-7-4/h1-3H,(H2,5,7)

InChI 密鑰

XFTQRUTUGRCSGO-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

應用

四组分合成咪唑烷类的基质。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 1

1 of 1

Synthetic Communications, 37, 247-247 (2007)
W H Lunn et al.
Xenobiotica; the fate of foreign compounds in biological systems, 22(11), 1239-1241 (1992-11-01)
1. The compound 2-aminopyrazine was given by oral gavage to normal rats and their urine collected. 2. A mercapturic acid containing the 2-aminopyrazine moiety was isolated from this urine. This represents the first example of this type of a metabolite
J F Cavalier et al.
Bioorganic & medicinal chemistry, 9(4), 1037-1044 (2001-05-17)
A series of 5-aryl- and 3,5-bis-aryl-2-amino-1,4-pyrazine derivatives 4 and 6, and related imidazolopyrazinones 7, has been synthesized, the aryl groups of which are catechol and/or phenol substituents. These compounds, tested against human keratinocyte cells stressed by UVB irradiation, showed high
Frédéric De Wael et al.
European journal of medicinal chemistry, 45(9), 3564-3574 (2010-06-24)
Based on the imidazo-[1,2-a]-pyrazin-3-(7H)-one scaffold, a dual action prodrug has been designed for combining antioxidant and anti-inflammatory activities, possibly unmasked upon oxidation. The construction of the target-molecule requires two building blocks, namely a 2-amino-1,4-pyrazine and a 2-ketoaldehyde. Attempts to synthesize
Anna Eriksson et al.
Biochemical pharmacology, 80(10), 1507-1516 (2010-08-14)
Aberrant signal transduction by mutant or overexpressed protein kinases has emerged as a promising target for treatment of acute myeloid leukemia (AML). We here present a novel low molecular weight kinase inhibitor, AKN-032, targeting the FMS-like tyrosine kinase 3 (FLT3)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持